Genome British Columbia
Jump to navigation
Jump to search
Genome British Columbia "is a research organization that invests in and manages large-scale genomics and proteomics research projects and science and technology platforms focused on areas of strategic importance such as human health, forestry, fisheries, ethics, agriculture and the environment. By working collaboratively with all levels of government, universities and industry, Genome BC is the catalyst for a vibrant, genomics-driven life sciences cluster with far reaching social and economic benefits for the province and Canada." [1]
Contents
Directors Term 2007-2008 [2]
- David Dolphin - , Professor Emeritus, University of British Columbia
- Alan Pelman - Vice Chair, Vice President, Technology - Canada, Weyerhaeuser Company Ltd
- Alan E. Winter - President and Chief Executive Officer, Genome BC
- Harold Coward - Former Director, Centre for Studies in Religion and Society, University of Victoria
- Natalie E. Dakers - Chief Executive Officer, Centre for Drug Research and Development
- Don Enns - President and Chief Executive Officer, CANTEST Ltd.
- Frank Holler - Chief Executive Officer and Fund Manager, BC Advantage Funds
- R. Hector MacKay-Dunn - Senior Partner, Farris, Vaughan, Wills & Murphy LLP
- Brad Popovich - Chief Executive Officer, Sirius Genomics
- Gerri Sinclair - Executive Director, World Center for Digital Media
- Michael Stevenson - President and Vice-Chancellor, Simon Fraser University
- Simon Sutcliffe - President and Chief Executive Officer, BC Cancer Agency
Non-Voting Members and Observers
- Martin Godbout (non-voting) - President and Chief Executive Officer, Genome Canada
- Moura Quayle (non-voting) - Deputy Minister of Advanced Education
Contact
Resources and articles
Related Sourcewatch
References
- ↑ Profile, Genome British Columbia, accessed September 22, 2007.
- ↑ Board of Directors, Genome British Columbia, accessed September 22, 2007.
